RIGEL PHARMACEUTICALS INC - RIGL
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Feb 24, 2026 | — | M | D | 4,000.0 | 0.0 | 0.0 | 0.0 | View | |
| Feb 24, 2026 | — | S | D | 4,000.0 | 36.36 | 145,440.0 | 12,722.0 | View | |
| Feb 24, 2026 | — | M | A | 4,000.0 | 24.0 | 96,000.0 | 16,722.0 | View | |
| Feb 19, 2026 | EVP & Chief Financial Officer | A | A | 20,636.0 | 0.0 | 0.0 | 76,337.0 | View | |
| Feb 19, 2026 | EVP, Chief Commercial Officer | A | A | 19,430.0 | 0.0 | 0.0 | 62,870.0 | View | |
| Feb 19, 2026 | EVP, Chief Medical Officer | A | A | 18,894.0 | 0.0 | 0.0 | 34,853.0 | View | |
| Feb 19, 2026 | CEO, President | A | A | 53,915.0 | 0.0 | 0.0 | 282,017.0 | View | |
| Feb 19, 2026 | EVP, GC, CCO & Corp Sec | A | A | 19,497.0 | 0.0 | 0.0 | 51,813.0 | View | |
| Feb 12, 2026 | CEO, President | F | D | 7,607.0 | 34.62 | 263,354.34 | 228,102.0 | View | |
| Feb 12, 2026 | EVP, Chief Commercial Officer | F | D | 3,546.0 | 34.62 | 122,762.52 | 43,440.0 | View | |
| Feb 12, 2026 | EVP, GC, CCO & Corp Sec | F | D | 3,546.0 | 34.62 | 122,762.52 | 32,316.0 | View | |
| Feb 12, 2026 | EVP & Chief Financial Officer | F | D | 3,546.0 | 34.62 | 122,762.52 | 55,701.0 | View | |
| Feb 12, 2026 | EVP, Chief Medical Officer | F | D | 3,758.0 | 34.62 | 130,101.96 | 15,959.0 | View | |
| Feb 04, 2026 | CEO, President | M | D | 40,000.0 | 0.0 | 0.0 | 0.0 | View | |
| Feb 04, 2026 | CEO, President | M | D | 40,000.0 | 0.0 | 0.0 | 0.0 | View | |
| Feb 04, 2026 | CEO, President | F | D | 14,110.0 | 36.01 | 508,101.1 | 235,709.0 | View | |
| Feb 04, 2026 | CEO, President | F | D | 35,424.0 | 37.0 | 1,310,688.0 | 249,819.0 | View | |
| Feb 04, 2026 | CEO, President | M | A | 40,000.0 | 27.4 | 1,096,000.0 | 285,243.0 | View | |
| Feb 04, 2026 | CEO, President | F | D | 35,211.0 | 37.0 | 1,302,807.0 | 245,243.0 | View | |
| Feb 04, 2026 | CEO, President | M | A | 40,000.0 | 27.4 | 1,096,000.0 | 280,454.0 | View | |
| Feb 04, 2026 | EVP, GC, CCO & Corp Sec | F | D | 3,968.0 | 36.01 | 142,887.68 | 35,862.0 | View | |
| Feb 04, 2026 | EVP & Chief Financial Officer | F | D | 5,488.0 | 36.01 | 197,622.88 | 59,247.0 | View | |
| Feb 04, 2026 | EVP, Chief Commercial Officer | F | D | 5,718.0 | 36.01 | 205,905.18 | 46,986.0 | View | |
| Feb 03, 2026 | — | A | A | 12,000.0 | 0.0 | 0.0 | 12,000.0 | View | |
| Dec 29, 2025 | EVP & Chief Financial Officer | M | D | 1,667.0 | 0.0 | 0.0 | 10,832.0 | View | |
| Dec 29, 2025 | EVP & Chief Financial Officer | M | D | 2,846.0 | 0.0 | 0.0 | 17,153.0 | View | |
| Dec 29, 2025 | EVP & Chief Financial Officer | M | D | 1,987.0 | 0.0 | 0.0 | 14,262.0 | View | |
| Dec 29, 2025 | EVP & Chief Financial Officer | M | A | 1,667.0 | 18.7 | 31,172.9 | 64,235.0 | View | |
| Dec 29, 2025 | EVP & Chief Financial Officer | M | A | 2,846.0 | 24.2 | 68,873.2 | 62,568.0 | View | |
| Dec 29, 2025 | EVP & Chief Financial Officer | M | A | 1,987.0 | 20.0 | 39,740.0 | 59,722.0 | View |